Antibacterial Prophylaxis vs no Prophylaxis for Hematological Malignancies Patients Before Allo-HSCT

NCT03733340 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

250

Enrollment

OTHER

Sponsor class

Conditions

Antibacterial Prophylaxis
Hematological Malignancies
Allogenetic Hematopoietic Stem Cell Transplantation
Imipenem

Interventions

DRUG: Imipenem

Sponsor

Nanfang Hospital, Southern Medical University